Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 300
- 试验地点
- 2
- 主要终点
- Number of Participants With COVID-19 Antibodies
研究概览
简要总结
The purpose of this study is to identify healthcare workers with SARS CoV 2 antibodies who have not been previously diagnosed and are presumed COVID-19 negative, then determine the level of immunity in this population which could inform further decisions about widespread antibody testing in a healthcare worker population.
详细描述
Enrolled participants will complete a survey gauging their level of confidence they will be antibody positive. Participants will then complete serologic testing for SARS CoV 2 IgG antibodies. The study will characterize the prevalence of antibody positivity in this population and assess whether there is a correlation between a pre-test confidence level using a Likert scale and actual antibody positivity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥ 18 years old.
- •Mayo Clinic employee in procedural and surgical area.
- •Suspected COVID-19 exposure.
- •Completed PCR test twice with negative results.
排除标准
- •Refusal to participate in this study.
结局指标
主要结局
Number of Participants With COVID-19 Antibodies
时间窗: 1 month
Presence of IgG antibodies detected
次要结局
- Ability to Predict Immune Status/Antibody Positivity(Single point in time prior to COVID-19 Antibody testing)
研究者
Mark A. Parkulo
Principal Investigator
Mayo Clinic